Atlas Infectious Disease Practice

Welcome to Atlas Infectious Disease Practice, where your health and the well-being of the community are our top priorities. We take pride in our critical role in safeguarding public health by providing a comprehensive range of services focused on the diagnosis, treatment, management, and prevention of infectious diseases. Our dedicated team of physicians and healthcare professionals are committed to delivering expert care and guidance. Explore the services and affiliations that make us a trusted partner in your health journey

Our Mission

At Atlas Infectious Disease Practice, our mission is clear: to provide exceptional, compassionate care for patients with infectious diseases, utilizing cutting-edge diagnostics and treatments to improve health outcomes and quality of life.

We achieve this by addressing a broad spectrum of infectious diseases, including but not limited to HIV, tuberculosis, hepatitis, sexually transmitted diseases, respiratory infections, and more. Our holistic approach covers both the treatment of existing infections and the prevention of future ones while offering personalized attention and education to empower our patients in managing their conditions.

Services

Services Provided

Hospital Consultation

Office Consultation

Immigration Exams

Travel Consultation

Telemedicine

Yellow Fever Vaccine

HIV medicine

Sexually transmitted infection

employee health

IV infusion

Latest news

Stay Informed

The Overlooked Impact of Infection

For half a century, psychiatrist Robert C Bransfield, MD, has practiced psychiatry in New Jersey, dedicating his career to one of the field’s most challenging areas: treatment-resistant psychiatric...

FDA Approves an Expanded Indication for Meningococcal Vaccine For Youngest Pediatric Population

In a move that links the quadrivalent meningococcal vaccine (MenQuadfi, Sanofi) throughout people’s lifetimes, the FDA has approved the expanded indication for the immunization for children aged...

Company Receives NIH Grant For Novel Investigational Antibiotic to Combat ‘Super Gonorrhea’

Image credit: Yassine Khalfalli, Unsplash This morning, TAXIS Pharmaceuticals announced it has received a $2.9 million grant, to be awarded over 3 years, from the National Institute of Allergy and...

Gene Duplication is Mechanism for Antifungal Resistance in Madurella fahalii-Caused Mycetoma

Models of the proteins produced by Madurella fahalii: CYP51A (A and C) and CYP51A2 (B and D). In each panel, itraconazole and heme are illustrated in a stick representation in the upper and lower...

Clinicians Discuss the State of Vaccines Today

This was a roundtable that was produced by our sister sites, Medical Economics and Infection Control Today. They brought together a powerhouse panel of experts, frontline physicians, national policy...

Top 5 Infectious Disease News Stories Week of May 18 to May 24

Ceftobiprole Launches Commercially in US Innoviva Specialty Therapeutics, which is a subsidiary of Innoviva, announced its antibiotic, ceftobiprole (Zevtera), is available for prescribing in the US...

FDA VRBPAC Makes Recommendations For 2025-2026 Formula for COVID-19 Vaccines

It has been a busy week for FDA-related news. On Tuesday, in an article published in the New England Journal of Medicine, FDA Commissioner Marty Makary, MD, MPH, and Vinay Prasad, MD, MPH, director of...

Reviewing Real-World Safety and Efficacy Data on C difficile Therapy Rebyota

Fecal microbiota, live-jslm (Rebyota ), which is indicated for treatment of recurrent C difficile, has been FDA approved for over 2 years now, and with it comes real-world efficacy and safety data...

How cholera bacteria outsmart viruses

When we think of cholera, most of us picture contaminated water and tragic outbreaks in vulnerable regions. But behind the scenes, cholera bacteria are locked in a fierce, microscopic war — one...

California Valley Fever Cases Surged in Q1 2025 Compared to Last Year

Central Valley, CA. Image credits: Unsplash In the first quarter of 2025, California reported 3,123 cases of Valley Fever (Coccidioidomycosis), nearly double the 10-year average for this period. This...

Long-Acting HIV Treatment in Low- and Middle-Income Countries

This Viewpoint discusses the need to develop products, such as long-acting antiretrovirals, for...

New Oral Antibiotic for Gonorrhea on the Horizon

A first-in-class oral antibiotic showed promise treating gonorrhea in a randomized clinical trial...

USPSTF Recommendation: Screening for Syphilis Infection During Pregnancy

This 2025 Recommendation Statement from the US Preventive Services Task Force recommends early...

USPSTF Review: Screening for Syphilis Infection During Pregnancy

This systematic review to support a 2025 US Preventive Services Task Force Recommendation Statement...

Patient Information: Screening for Syphilis Infection During Pregnancy

This JAMA Patient Page describes syphilis infection, risks of congenital syphilis during pregnancy...

Maternal Screening for Congenital Syphilis

Often dismissed as a deadly and dreaded disease of the past, syphilis has made a forceful and...

One Million New Pediatric HIV Cases Predicted If PEPFAR Funding Is Cut

For the past 2 decades, the US President’s Emergency Plan for AIDS Relief (PEPFAR) has provided more...

FDA Clears First At-Home Test for Chlamydia, Gonorrhea, and Trichomoniasis

The US Food and Drug Administration (FDA) recently authorized the first at-home test for chlamydia...

Nonrecommended Antivirals Among Medicare Beneficiaries With HIV

This cross-sectional study examines contemporary evidence on the extent to which Medicare...

Syphilis Exposure During Pregnancy and Childhood Hospital Admissions

This cohort study compares rates of all-cause hospitalization in children exposed to syphilis during...

Communicable disease threats report, 17-23 May 2025, week 21

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 17-23 May 2025...

Accepted insurances

Schedule appointment

We Are Dedicated To Your Health!

Better Care Starts With Us!

Testimonials

What Our Patients Say About Us!